Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.485
+0.035 (2.41%)
At close: Sep 30, 2026, 4:00 PM EDT
1.457
-0.028 (-1.86%)
After-hours: Sep 30, 2026, 7:51 PM EDT
Enveric Biosciences Employees
As of December 31, 2025, Enveric Biosciences had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,014,755
Market Cap
6.65M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 6 | 0 | - | 5 | 1 |
| Dec 31, 2024 | 6 | -1 | -14.29% | 5 | 1 |
| Dec 31, 2023 | 7 | -19 | -73.08% | 7 | 0 |
| Dec 31, 2022 | 26 | 2 | 8.33% | 25 | 1 |
| Dec 31, 2021 | 24 | 21 | 700.00% | 23 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| Evogene | 38 |
| Bolt Biotherapeutics | 23 |
| Processa Pharmaceuticals | 12 |
| Ernexa Therapeutics | 7 |
| Creative Medical Technology Holdings | 4 |
| Acurx Pharmaceuticals | 4 |
| Kairos Pharma | 4 |
ENVB News
- 15 days ago - Enveric receives Notice of Allowance from USPTO for application for EVM401 - TheFly
- 15 days ago - Enveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series - Business Wire
- 4 weeks ago - Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference - Business Wire
- 6 weeks ago - Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026 - Business Wire
- 1 month ago - Enveric Biosciences reports new preclinical data on EB-003 - TheFly
- 1 month ago - Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003 - Business Wire
- 2 months ago - Enveric ‘welcomes’ final FDA guidance for psychedelic drug development - TheFly
- 2 months ago - Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development - Business Wire